NCT06644924 - A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma | Biotech Hunter

Enrollment

118

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

June 4, 2025

Study Completion Date

June 4, 2025

Conditions

Asthma

Interventions

COMBINATION_PRODUCT

Intervention: AS MDI

Drug Treatment: (Albuterol Sulfate metered dose inhaler \[AS MDI\] - PT007) Randomized participants will receive a single-dose (2 inhalations)

COMBINATION_PRODUCT

Intervention: Ventolin Evohaler

Drug: Treatment (Ventolin Evohaler) Randomized participants will receive a single-dose (2 inhalations)

COMBINATION_PRODUCT

Intervention: Placebo matching AS MDI

Drug: Treatment (Placebo MDI) Randomized participants will receive a single-dose (2 inhalations to match AS MDI)

Trial Locations (22)

21162

Research Site, White Marsh

27607

Research Site, Raleigh

32308

Research Site, Tallahassee

33175

Research Site, Miami

33607

Research Site, Tampa

33765

Research Site, Clearwater

53228

Research Site, Milwaukee

63141

Research Site, St Louis

63301

Research Site, Saint Charles

65203

Research Site, Columbia

77901

Research Site, Victoria

78759

Research Site, Austin

79912

Research Site, El Paso

90048

Research Site, Los Angeles

92024

Research Site, Encinitas

92123

Research Site, San Diego

92663

Research Site, Newport Beach

93534

Research Site, Lancaster

95117

Research Site, San Jose

95207

Research Site, Stockton

97202

Research Site, Portland

97504

Research Site, Medford